CD19 and neoplasm: To rule out the off‐target effect of the CD19 immunotoxin, three human CD19− tumor cell lines were analyzed with biotinylated bivalent human CD19 immunotoxin using flow cytometry: (a) CCRF‐CEM, (b) M14, and (c) MD‐MBA‐231.